Not to mention the expectation of commercial supply of Jelli-Grow in mid-2023.
I think it's interesting in the Cash Flow sheet that they've only got 1.85 quarters of funding remaining, and have not said that they're planning on a cash raise but instead "the company is confident it will have access to sufficient capital when needed".
R&D tax rebate due soon, second pilot spin with some sales by end of Feb/early March.
Their R&D spend is relatively low compared to other biotechs, which also means their rebate won't be a big payday. It's going to be dependent on the revenue of the next pilot spin sales whether they will need to do a cash raise by the next quarter.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Not to mention the expectation of commercial supply of...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NC6 (ASX) to my watchlist
|
|||||
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.612M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 18688 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 48800 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 18688 | 0.020 |
1 | 78947 | 0.019 |
1 | 52556 | 0.018 |
1 | 103305 | 0.017 |
1 | 496600 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 48800 | 1 |
0.023 | 4782 | 1 |
0.026 | 36300 | 2 |
0.028 | 70000 | 1 |
0.029 | 19998 | 1 |
Last trade - 16.12pm 14/06/2024 (20 minute delay) ? |
Featured News
NC6 (ASX) Chart |
Day chart unavailable